Skip to content

Hi David, your investor insight at a glance.

Latest Insight
February 18, 2026

2025 was another year of impressive performance for PSH on an absolute and relative basis.

Read more
Your Feed

Insights

Webinars

Events

Catch up on latest Cadarn Fund Partner RNS
Latest Press
Investment Trust Show: can big dividends make up for weak share price performance? The challenges facing renewable energy and infrastructure trusts.
2 March 2026

AJ Bell Money & Markets: Investment Trust Show: can big dividends make up for weak share price performance? The challenges facing renewable energy and infrastructure trusts.

CVC Income & Growth
RTW: We’re in the early innings of a biotech recovery
19 February 2026

Citywire: RTW: We’re in the early innings of a biotech recovery

RTW
RTW Biotech’s Wong: GLP-1s are tackling the ‘largest pharmaceutical event the industry has ever seen’
26 January 2026

Portfolio Adviser: RTW Biotech’s Wong: GLP-1s are tackling the ‘largest pharmaceutical event the industry has ever seen’

RTW
Investor Portal

Exclusive access for professional investors

The Investor Portal provides professional investors with exclusive access to upcoming Cadarn events, detailed fund portfolio insights and associated fund materials. A dedicated information hub that offers an insight into our fund partners’ respective investment approaches, market insights and fund news.

Sign up
Cadarn Capital EU A/S is a tied agent of Acolin Europe AG, authorized and regulated by BaFin.
This is a marketing communication. Please refer to the prospectus of the respective funds and to the KID / KIID before making any final investment decisions. Past performance does not predict future returns.